Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide
Plants · 12.05.2023 · 12 (10) · 1969
DOI: 10.3390/plants12101969 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plants, online erschienen am 12.05.2023. Verfasst von Rosa Tundis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In spite of the progress in treatment strategies, cancer remains a major cause of death worldwide. Therefore, the main challenge should be the early diagnosis of cancer and the design of an optimal therapeutic strategy to increase the patient’s life expectancy as well as the continuation of the search for increasingly active and selective molecules for the treatment of different forms of cancer. In the recent decades, research in the field of natural compounds has increasingly shifted towards advanced and molecular level understandings, thus leading to the development of potent anti-cancer agents. Among them is the diterpene lactone andrographolide, isolated from Andrographis paniculata (Burm.f.) Wall. ex Nees that showed shows a plethora of biological activities, including not only anti-cancer activity, but also anti-inflammatory, anti-viral, anti-bacterial, neuroprotective, hepatoprotective, hypoglycemic, and immunomodulatory properties. Andrographolide has been shown to act as an anti-tumor drug by affecting specific molecular targets that play a part in the development and progression of several cancer types including breast, lung, colon, renal, and cervical cancer, as well as leukemia and hepatocarcinoma. This review comprehensively and systematically summarized the current research on the potential anti-cancer properties of andrographolide highlighting its mechanisms of action, pharmacokinetics, and potential side effects and discussing the future perspectives, challenges, and limitations of use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
- Research Institute of Integrative Life Sciences, Dongguk University-Seoul, Goyangsi 10326, Republic of Korea.
- Department of Botany and Biotechnology, Karimganj College, Assam University, Assam 788710, India.
- Department of Life Science and Bioinformatics, Assam University, Assam 788011, India.
ORCID-Profile: Rosa Tundis, Jayanta Kumar Patra, Rajat Nath, Gitishree Das, Monica Rosa Loizzo
Zitieren
APA
Tundis, R., Patra, J. K., Bonesi, M., Das, S., Nath, R., Das Talukdar, A., Das, G., & Loizzo, M. R. (2023). Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide. Plants, 12(10), 1969. https://doi.org/10.3390/plants12101969
Vancouver
Tundis R, Patra JK, Bonesi M, Das S, Nath R, Das Talukdar A, et al. Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide. Plants. 2023;12(10):1969. doi:10.3390/plants12101969
BibTeX
@article{Tundis2023,
author = {Tundis, Rosa and Patra, Jayanta Kumar and Bonesi, Marco and Das, Subrata and Nath, Rajat and Das Talukdar, Anupam and Das, Gitishree and Loizzo, Monica Rosa},
title = {Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide},
journal = {Plants},
year = {2023},
volume = {12},
number = {10},
pages = {1969},
doi = {10.3390/plants12101969}
}
EUVIMED